These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vesico-ureteric reflux and urinary tract development in the Pax2 1Neu+/- mouse. Murawski IJ, Myburgh DB, Favor J, Gupta IR. Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1736-45. PubMed ID: 17881463 [Abstract] [Full Text] [Related]
5. Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies. Schimmenti LA, Pierpont ME, Carpenter BL, Kashtan CE, Johnson MR, Dobyns WB. Am J Med Genet; 1995 Nov 06; 59(2):204-8. PubMed ID: 8588587 [Abstract] [Full Text] [Related]
6. PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism. Amiel J, Audollent S, Joly D, Dureau P, Salomon R, Tellier AL, Augé J, Bouissou F, Antignac C, Gubler MC, Eccles MR, Munnich A, Vekemans M, Lyonnet S, Attié-Bitach T. Eur J Hum Genet; 2000 Nov 06; 8(11):820-6. PubMed ID: 11093271 [Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme and angiotensin type 2 receptor gene genotype distributions in Italian children with congenital uropathies. Rigoli L, Chimenz R, di Bella C, Cavallaro E, Caruso R, Briuglia S, Fede C, Salpietro CD. Pediatr Res; 2004 Dec 06; 56(6):988-93. PubMed ID: 15470205 [Abstract] [Full Text] [Related]
8. Congenital anomalies of the kidney and urinary tract--role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. Pope JC, Brock JW, Adams MC, Miyazaki Y, Stephens FD, Ichikawa I. J Urol; 2001 Jan 06; 165(1):196-202. PubMed ID: 11125405 [Abstract] [Full Text] [Related]
10. Genetics of vesicoureteral reflux and congenital anomalies of the kidney and urinary tract. Lee KH, Gee HY, Shin JI. Investig Clin Urol; 2017 Jun 06; 58(Suppl 1):S4-S13. PubMed ID: 28612055 [Abstract] [Full Text] [Related]
11. Vesicoureteric reflux and renal malformations: a developmental problem. Murawski IJ, Gupta IR. Clin Genet; 2006 Feb 06; 69(2):105-17. PubMed ID: 16433689 [Abstract] [Full Text] [Related]
13. Pax2 in development and renal disease. Dressler GR, Woolf AS. Int J Dev Biol; 1999 Feb 06; 43(5):463-8. PubMed ID: 10535325 [Abstract] [Full Text] [Related]
14. Role of angiotensin in the development of the kidney and urinary tract. Pope JC, Nishimura H, Ichikawa I. Nephrologie; 1998 Feb 06; 19(7):433-6. PubMed ID: 9857380 [Abstract] [Full Text] [Related]
15. ACE serum level and I/D gene polymorphism in children with obstructive uropathies and other congenital anomalies of the kidney and urinary tract. Kostadinova ES, Miteva LD, Stanilova SA. Nephrology (Carlton); 2017 Aug 06; 22(8):609-616. PubMed ID: 27206329 [Abstract] [Full Text] [Related]
18. PAX genes in development and disease: the role of PAX2 in urogenital tract development. Eccles MR, He S, Legge M, Kumar R, Fox J, Zhou C, French M, Tsai RW. Int J Dev Biol; 2002 Jul 06; 46(4):535-44. PubMed ID: 12141441 [Abstract] [Full Text] [Related]
19. The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies. Cunliffe HE, McNoe LA, Ward TA, Devriendt K, Brunner HG, Eccles MR. J Med Genet; 1998 Oct 06; 35(10):806-12. PubMed ID: 9783702 [Abstract] [Full Text] [Related]
20. Vesicoureteral reflux and other urinary tract malformations in mice compound heterozygous for Pax2 and Emx2. Boualia SK, Gaitan Y, Murawski I, Nadon R, Gupta IR, Bouchard M. PLoS One; 2011 Oct 06; 6(6):e21529. PubMed ID: 21731775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]